April 21, 2015 9:36 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Analysts at Cantor Fitzgerald initiated coverage on
Ross Stores, Inc. (NASDAQ: ROST) with a Hold rating. The target price for Ross Stores is set to $110. Ross Stores' shares closed at $102.29 yesterday.Analysts at Wunderlich initiated coverage on
Jernigan Capital Inc. (NYSE: JCAP) with a Buy rating. The target price for Jernigan Capital is set to $25. Jernigan Capital's shares closed at $21.30 yesterday.Analysts at FBR Capital initiated coverage on
Regulus Therapeutics Inc (NASDAQ: RGLS) with a Outperform rating. The target price for Regulus Therapeutics is set to $30. Regulus Therapeutics' shares closed at $17.18 yesterday.Stifel Nicolaus initiated coverage on
Summit Materials Inc (NYSE: SUM) with a Buy rating. The target price for Summit Materials is set to $28. Summit Materials' shares closed at $24.22 yesterday.FBR Capital initiated coverage on
Genocea Biosciences Inc (NASDAQ: GNCA) with a Outperform rating. The target price for Genocea Biosciences is set to $20. Genocea Biosciences' shares closed at $12.93 yesterday.Analysts at FBR Capital initiated coverage on
Zafgen Inc (NASDAQ: ZFGN) with a Outperform rating. The target price for Zafgen is set to $60. Zafgen's shares closed at $36.58 yesterday.Raymond James initiated coverage on
Community Bank System, Inc. (NYSE: CBU) with a Market Perform rating. Community Bank System's shares closed at $35.64 yesterday.Analysts at FBR Capital initiated coverage on
Biocryst Pharmaceuticals, Inc. (NASDAQ: BCRX) with a Outperform rating. The target price for Biocryst Pharmaceuticals is set to $18. Biocryst Pharmaceuticals' shares closed at $10.29 yesterday.FBR Capital initiated coverage on
Corcept Therapeutics Incorporated (NASDAQ: CORT) with a Outperform rating. The target price for Corcept Therapeutics is set to $12. Corcept Therapeutics' shares closed at $5.98 yesterday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.